IFP Advisors’s Coherus Oncology CHRS Stock Holding History

IFP Advisors’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.03K	Sell	610 -68	-10%	-$121	﹤0.01%	4209
2025 Q4	$963	Buy	678 +291	+75%	+$424	﹤0.01%	4085
2025 Q3	$635	Buy	387 +10	+3%	+$11	﹤0.01%	4103
2025 Q2	$276	Buy	377 +153	+68%	+$132	﹤0.01%	4572
2025 Q1	$181	Hold	224	–	–	﹤0.01%	3693
2024 Q4	$309	Buy	+224	New	+$251	﹤0.01%	3560
2023 Q1	–	Sell	-1,000	Closed	-$16K	–	3540
2022 Q4	$16K	Buy	+1,000	New	+$7.69K	﹤0.01%	3057
2022 Q1	–	Sell	-53	Closed	-$1K	–	4550
2021 Q4	$1K	Buy	+53	New	+$927	﹤0.01%	2959
2021 Q1	–	Sell	-18	Closed	-$306	–	3027
2020 Q4	$0	Sell	18 -17	-49%	-$303	﹤0.01%	2959
2020 Q3	$0	Buy	+35	New	+$651	﹤0.01%	2852
2020 Q2	–	Sell	-161	Closed	-$2.73K	–	2757
2020 Q1	$3K	Buy	161 +21	+15%	+$388	﹤0.01%	2232
2019 Q4	$3K	Hold	140	–	–	﹤0.01%	2352
2019 Q3	$3K	Buy	+140	New	+$2.8K	﹤0.01%	2517

Other funds holding CHRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Alyeska Investment Group

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return